(Q36329164)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323560%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323560%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323560%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

author name string

Christian Hölscher

series ordinal

1

1 reference

13 August 2017

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323560%20AND%20SRC:MED&resulttype=core&format=json

Reviews in the Neurosciences

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323560%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323560%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323560%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

181-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323560%20AND%20SRC:MED&resulttype=core&format=json

Neuronal membrane cholesterol loss enhances amyloid peptide generation

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

ADAMs family members as amyloid precursor protein alpha-secretases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Reductions in beta-amyloid concentrations in vivo by the gamma-secretase inhibitors BMS-289948 and BMS-299897.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Short-term beta-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP + PS1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Inflammatory mediator and beta-amyloid (25-35)-induced ceramide generation and iNOS expression are inhibited by vitamin E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Distinct components of spatial learning revealed by prior training and NMDA receptor blockade.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid, and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Hydrogen peroxide mediates amyloid beta protein toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

A synaptic model of memory: long-term potentiation in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Neocortical synaptic bouton number is maintained despite robust amyloid deposition in APP23 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Alzheimer's disease: transiently developing dendritic changes in pyramidal cells of sector CA1 of the Ammon's horn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Methodological variables in the assessment of beta amyloid neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

A beta (25-35) peptide displays H2O2-like reactivity towards aqueous Fe2+, nitroxide spin probes, and synaptosomal membrane proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Cholinergic agonists and interleukin 1 regulate processing and secretion of the Alzheimer beta/A4 amyloid protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Age- and region-dependent alterations in Abeta-degrading enzymes: implications for Abeta-induced disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

BACE1 is the major beta-secretase for generation of Abeta peptides by neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

P2Y2 nucleotide receptors enhance alpha-secretase-dependent amyloid precursor protein processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

The role of insulin and insulin-like growth factor I in the molecular and cellular mechanisms underlying the pathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Oxidative neuronal injury. The dark side of ERK1/2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Gamma-secretase exists on the plasma membrane as an intact complex that accepts substrates and effects intramembrane cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Secretion of nerve growth factor from septum stimulates neurite outgrowth and release of the amyloid protein precursor of Alzheimer's disease from hippocampal explants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

NSAID and antioxidant prevention of Alzheimer's disease: lessons from in vitro and animal models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

In vitro aggregation facilities beta-amyloid peptide-(25-35)-induced amnesia in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Clioquinol, a drug for Alzheimer's disease specifically interfering with brain metal metabolism: structural characterization of its zinc(II) and copper(II) complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

The Calcium Rationale in Aging and Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Does my mouse have Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

A nontransgenic mouse model shows inducible amyloid-beta (Abeta) peptide deposition and elucidates the role of apolipoprotein E in the amyloid cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Rediscovering an old friend, IGF-I: potential use in the treatment of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Intraventricular infusions of antibodies to amyloid-beta-protein precursor impair the acquisition of a passive avoidance response in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Induction of apoptosis by proteasome inhibitors in B-CLL cells is associated with downregulation of CD23 and inactivation of Notch2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Convergence of p53 and TGF-beta signaling networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Glucagon-like peptide-1 receptor is involved in learning and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Inflammatory mechanisms in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Alzheimer amyloid beta-peptides exhibit ionophore-like properties in human erythrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Effects of injected Alzheimer beta-amyloid cores in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Activation of K+ channels and suppression of neuronal activity by secreted beta-amyloid-precursor protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Lack of Alzheimer pathology after beta-amyloid protein injections in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Differential effects of amyloid peptides beta-(1-40) and beta-(25-35) injections into the rat nucleus basalis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Effect of beta-amyloid block of the fast-inactivating K+ channel on intracellular Ca2+ and excitability in a modeled neuron

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Comparative effects of GLP-1 and GIP on cAMP production, insulin secretion, and in vivo antidiabetic actions following substitution of Ala8/Ala2 with 2-aminobutyric acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

APP transgenesis: approaches toward the development of animal models for Alzheimer disease neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

The disintegrin/metalloprotease ADAM 10 is essential for Notch signalling but not for alpha-secretase activity in fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Coordinated and widespread expression of gamma-secretase in vivo: evidence for size and molecular heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Polymorphisms in neprilysin gene affect the risk of Alzheimer's disease in Finnish patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

The association of apolipoprotein E polymorphism with memory: a population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Molecular mechanisms of NCAM function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Behavioral changes in transgenic mice expressing both amyloid precursor protein and presenilin-1 mutations: lack of association with amyloid deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Prostaglandins play a role in memory consolidation in the chick.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Possible Causes of Alzheimer's Disease: Amyloid Fragments, Free Radicals, and Calcium Homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

HFS-induced long-term potentiation and LFS-induced depotentiation in area CA1 of the hippocampus are not good models for learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Redox-active metals, oxidative stress, and Alzheimer's disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Bright and dark sides of nitric oxide in ischemic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Free radicals and superoxide dismutase in blood of patients with Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent "gamma-secretase" cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

The role of viruses and of APOE in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

The gamma-secretase complex: machinery for intramembrane proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Increased risk of type 2 diabetes in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Beta-amyloid (1-42)-induced learning and memory deficits in mice: involvement of oxidative burdens in the hippocampus and cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Statins and the risk of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

The glamour and gloom of glycogen synthase kinase-3

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Progressive age-related impairment of cognitive behavior in APP23 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Glutamate-stimulated secretion of amyloid precursor protein from cortical rat brain slices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Changes of p53 in the brains of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

NICE proposes to withdraw Alzheimer's drugs from NHS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the alpha -secretase ADAM 10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Cellular delivery of NGF does not alter the expression of beta-amyloid immunoreactivity in young or aged nonhuman primates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

In vivo neurotoxicity of beta-amyloid [beta(1-40)] and the beta(25-35) fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Transgenic mice expressing the PS1-A246E mutation: effects on spatial learning, exploration, anxiety, and motor coordination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Cell death induced by β-amyloid 1–40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Metabotropic glutamate receptors regulate APP processing in hippocampal neurons and cortical astrocytes derived from fetal rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Beta-amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Amyloid fibril toxicity in Alzheimer's disease and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Mice deficient in BACE1, the Alzheimer's beta-secretase, have normal phenotype and abolished beta-amyloid generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Nitric oxide: a downstream mediator of calcium toxicity in the ischemic cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Basic FGF attenuates amyloid beta-peptide-induced oxidative stress, mitochondrial dysfunction, and impairment of Na+/K+-ATPase activity in hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Oxidative stress hypothesis in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Amyloid precursor proteins protect neurons of transgenic mice against acute and chronic excitotoxic injuries in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Degenerative and protective signaling mechanisms in the neurofibrillary pathology of AD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Mother's legacy: mitochondrial DNA mutations and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Neuroprotective signal transduction: relevance to stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

beta-Amyloid precursor protein metabolites and loss of neuronal Ca2+ homeostasis in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

beta-Amyloid precursor protein and Alzheimer's disease: the peptide plot thickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Calcium-destabilizing and neurodegenerative effects of aggregated beta-amyloid peptide are attenuated by basic FGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Reversion of beta 25-35-amyloid peptide-induced amnesia by NMDA receptor-associated glycine site agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Amyloid precursor protein family-induced neuronal death is mediated by impairment of the neuroprotective calcium/calmodulin protein kinase IV-dependent signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Anti-inflammatory drugs in the fight against Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Memory and long-term potentiation (LTP) dissociated: normal spatial memory despite CA1 LTP elimination with Kv1.4 antisense

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Memory-enhancing effects of secreted forms of the beta-amyloid precursor protein in normal and amnestic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Overexpression of IRS2 in isolated pancreatic islets causes proliferation and protects human beta-cells from hyperglycemia-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Neurotrophic and neuroprotective effects of hAPP in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Clinical comparison of Alzheimer's disease in pedigrees with the codon 717 Val→Ile mutation in the amyloid precursor protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Behavioral and anatomical deficits in mice homozygous for a modified beta-amyloid precursor protein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Reactive oxygen species and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Apolipoprotein E ε4 allele is associated with deposition of amyloid β-protein following head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Alzheimer amyloid protein precursor complexes with brain GTP-binding protein G(o)

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Role of neurotransmission in the regulation of amyloid beta-protein precursor processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Normal spatial learning despite regional inhibition of LTP in mice lacking Thy-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Induction of cyclo-oxygenase 2 in brains of patients with Down's syndrome and dementia of Alzheimer type: specific localization in affected neurones and axons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Decay characteristics of HIV-1-infected compartments during combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Functional reconstitution of gamma-secretase through coordinated expression of presenilin, nicastrin, Aph-1, and Pen-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

A new Alzheimer's disease interventive strategy: GLP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Ion channel hypothesis for Alzheimer amyloid peptide neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Cholesterol efflux as a critical component of Alzheimer's disease pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Pw1/Peg3 is a potential cell death mediator and cooperates with Siah1a in p53-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Transforming growth factors-beta protect primary rat hippocampal neuronal cultures from degeneration induced by beta-amyloid peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Behavioural and histopathological analyses of ibuprofen treatment on the effect of aggregated Abeta(1-42) injections in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Abeta amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

An Alzheimer's disease hypothesis based on transcriptional dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Electrophysiological studies on the hippocampus and prefrontal cortex assessing the effects of amyloidosis in amyloid precursor protein 23 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Intracerebral beta-amyloid(25-35) produces tissue damage: is it neurotoxic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Somatostatin regulates brain amyloid beta peptide Abeta42 through modulation of proteolytic degradation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

APP gene family. Alternative splicing generates functionally related isoforms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Ca2+/calmodulin-regulated nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

New Alzheimer's therapy suggested.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Differential contribution of the three Aph1 genes to gamma-secretase activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Activation of microglial cells by PrP and beta-amyloid fragments raises intracellular calcium through L-type voltage sensitive calcium channels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Amyloid beta protein (25-35) stimulation of phospholipases A, C and D activities of LA-N-2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

A role for the beta-amyloid precursor protein in memory?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

gamma-Secretase, Notch, Abeta and Alzheimer's disease: where do the presenilins fit in?

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

The role of heparan sulfate proteoglycans in the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Failure of beta-amyloid protein fragment 25-35 to cause hippocampal damage in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-term rather than long-term memory in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Ibuprofen: effect on inducible nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Superoxide free radical and intracellular calcium mediate A beta(1-42) induced endothelial toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Roles of MAPKKK ASK1 in stress-induced cell death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

beta-Amyloid-mediated vasoactivity and vascular endothelial damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

21 January 2018

Putting the rap on Akt.

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Hippocampal synaptic plasticity and glutamate receptor regulation: influences of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Age-dependent cognitive decline in the APP23 model precedes amyloid deposition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Insulin-like growth factor-I, cognition and brain aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Amyloid, Presenilins, and Alzheimer’s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Generation of APLP2 KO mice and early postnatal lethality in APLP2/APP double KO mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Deciphering the molecular basis of memory failure in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Beta-amyloid-mediated inhibition of NMDA receptor-dependent long-term potentiation induction involves activation of microglia and stimulation of inducible nitric oxide synthase and superoxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Alzheimer's disease: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

beta-site amyloid precursor protein cleaving enzyme 1 increases amyloid deposition in brain parenchyma but reduces cerebrovascular amyloid angiopathy in aging BACE x APP[V717I] double-transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

A fluid connection: cholesterol and Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyte-derived macrophages: implications for the pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Cerebral amyloid angiopathy and gene polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Mice deficient for the amyloid precursor protein gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Activation of Multiple Metabotropic Glutamate Receptor Subtypes Prevents NMDA-induced Excitotoxicity in Rat Hippocampal Slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Amyloid-associated proteins α1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FREVNEURO.2005.16.3.181

Beta-amyloid induced reduction in synaptic transmission is reversed by inhibitors of nitric oxide synthase

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1097/00001756-199804200-00052

Identifiers

DOI

10.1515/REVNEURO.2005.16.3.181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16323560%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference